Welcome to our dedicated page for Accenture Plc Ireland SEC filings (Ticker: ACN), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
The Accenture plc (ACN) SEC filings page brings together the company’s official disclosures to the U.S. Securities and Exchange Commission, including annual and quarterly financial reports, proxy materials and current reports on significant events. As a New York Stock Exchange‑listed company incorporated in Ireland, Accenture uses these filings to provide detailed information on its financial performance, governance, strategy and material developments.
Accenture’s Form 8‑K current reports frequently furnish earnings releases for quarterly and annual periods, outlining revenues, operating margin, earnings per share, bookings, free cash flow and other key metrics. These 8‑K filings also describe the company’s use of non‑GAAP measures such as free cash flow, local‑currency growth and adjusted results that exclude specified business optimization costs, along with reconciliations to GAAP figures. Other 8‑K filings disclose leadership and organizational changes, including updates to Accenture’s growth model and senior management roles.
The company’s definitive proxy statement (DEF 14A) provides extensive detail on corporate governance, board structure, director nominees, executive compensation programs, share incentive plans and shareholder proposals. It also discusses Accenture’s strategy to be the reinvention partner of choice for clients, its Reinvention Services structure, and multi‑year trends in revenue growth, margins, earnings and cash returned to shareholders.
Through this page, users can access Accenture’s 10‑K annual reports, 10‑Q quarterly reports, 8‑K current reports, proxy statements and related exhibits as they are filed with the SEC’s EDGAR system. Stock Titan enhances these documents with AI‑powered summaries that highlight the main points of lengthy filings, explain non‑GAAP reconciliations, and surface items such as compensation plans and governance proposals. Investors tracking ACN can use these filings to review historical performance, understand management’s reporting practices and monitor material events affecting the company.
Accenture plc director reports small dividend-related RSU grant. On 11/14/2025, a director of Accenture plc received 6 Class A ordinary shares through a grant of restricted share units at a price of $0, made under anti-dilution provisions tied to Accenture's cash dividend. Following this adjustment, the director beneficially owns 1,134 Class A ordinary shares in direct ownership.
Accenture plc director reports small RSU adjustment tied to dividend. A board member of Accenture plc (ACN) reported receiving 6 Class A ordinary shares on 11/14/2025 through an automatic grant of restricted share units. The filing explains this RSU grant was made under anti-dilution provisions of previously granted awards to reflect Accenture’s payment of a cash dividend. The shares were acquired at a stated price of $0, and following this adjustment the director now beneficially owns 7,266 Class A ordinary shares directly.
Accenture plc executive Manish Sharma, the company’s Chief Strategy & Services Officer, reported equity transactions in Accenture Class A ordinary shares on 11/14/2025. He acquired 93 shares at $0, described as a grant of restricted share units (RSUs) made under anti-dilution provisions to reflect Accenture’s payment of a cash dividend. He also disposed of 37 shares at $246.62. Following these transactions, Sharma directly beneficially owns 1,991 Class A ordinary shares of Accenture.
Accenture plc reported a Form 4 transaction for its Chief Financial Officer. On 11/14/2025, the officer acquired 26 Class A ordinary shares at $0 per share through a grant of restricted share units (RSUs) issued under anti-dilution provisions to reflect Accenture’s cash dividend. On the same date, 3 Class A ordinary shares were disposed of at $246.62 per share, reported with transaction code "F," indicating shares withheld, typically for tax purposes. Following these transactions, the officer beneficially owned 8,693 Class A ordinary shares in direct form.
Accenture plc (ACN) filed a Form 4 reporting equity compensation activity for its Chief Operating Officer, Catherine Kiernan Hogan. On 11/14/2025 she received 47 Class A ordinary shares in the form of restricted share units granted under anti-dilution provisions tied to Accenture's cash dividend, at a stated price of $0 per share. On the same date, 8 Class A ordinary shares were disposed of at $246.62 per share, typically reflecting shares withheld to cover taxes on the award. Following these transactions, she beneficially owned 10,168 Class A ordinary shares directly and 2,048 Class A ordinary shares held indirectly in a family trust.
Accenture plc (ACN) reported insider equity activity by its General Counsel and Corporate Secretary, Joel Unruch. On 11/14/2025, he received 120 Class A ordinary shares at a price of $0, reflecting a grant of restricted share units under anti-dilution provisions tied to Accenture’s cash dividend. On the same date, 30 Class A ordinary shares were disposed of at $246.62 per share, consistent with a tax-related transaction. Following these transactions, Unruch beneficially owns 23,707 Class A ordinary shares, held directly.
Accenture plc (ACN) reported an insider equity transaction by its Co-CEO Asia Pacific, Atsushi Egawa. On 11/14/2025, Egawa received 26 Class A ordinary shares in the form of restricted share units (RSUs) at a price of $0 per share. The filing explains that these RSUs were granted under anti-dilution provisions of previously granted RSU awards to reflect Accenture’s payment of a cash dividend, meaning the grant is an adjustment tied to the dividend rather than a new incentive package. Following this transaction, Egawa beneficially owns 14,872 Class A ordinary shares directly and 56 Class A ordinary shares indirectly through an immediate family member.
Accenture plc (ACN) director Masahiko Uotani reported an equity award in a Form 4 filing. On 11/14/2025, he acquired 5 Class A ordinary shares in the form of restricted share units (RSUs) at a price of $0, increasing his beneficial ownership to 624 shares held directly. The filing explains that these RSUs were granted under the anti-dilution provisions of earlier RSU awards to reflect Accenture plc's payment of a cash dividend, meaning the grant adjusts prior awards rather than representing a new open-market purchase.
Accenture plc (ACN) director Jaime Ardila reported a grant of 5 Class A ordinary shares in the form of restricted share units on 11/14/2025. The filing explains that these RSUs were issued under the anti-dilution provisions of previously granted RSU awards to reflect Accenture’s payment of a cash dividend, meaning they are an adjustment rather than a new incentive grant. The RSUs were acquired at a stated price of $0, and following this transaction Ardila beneficially owns 12,129 Class A ordinary shares, held directly.
Accenture plc director reports small RSU adjustment after dividend
A director of Accenture plc (ACN) reported receiving 7 Class A ordinary shares on 11/14/2025, shown at a price of $0. The filing explains this as a grant of restricted share units (RSUs) under anti-dilution provisions of previously granted RSU awards, made to reflect Accenture’s payment of a cash dividend. Following this adjustment, the director beneficially owns 8,580 Class A ordinary shares held directly.